Camson Bio Technologies Limited (BSE:538858) agreed to spin-off Camson Seeds Limited on September 24, 2014. Under the transaction, Camson Bio Technologies proposes to demerge, transfer and vest with Camson Seeds Limited, the entire properties, assets, liabilities, rights, operations of its seeds business. Upon the scheme becoming effective, existing shareholders of Camson Bio Technologies will get one equity share of Camson Seeds Limited for every share held in Camson Bio Technologies. Camson Seeds Limited will be listed on the stock exchange on which shares of Camson Bio Technologies Limited are listed and stock exchange where Camson Bio Technologies Limited is intending to list its shares after obtaining requisite approval. The scheme is conditional and is subject to approval by the Honourable High Court of Karnataka and being approved by the requisite majority in number and value of shareholders and creditors of Camson Bio Technologies and Camson Seeds as may be directed by court. The transaction was approved by the Board of Directors of Camson Bio Technologies Limited on September 24, 2014. Shareholders and creditors in the court convened meeting held on April 23, 2015 has approved the transaction. The High Court of Karnataka approved the transaction on August 4, 2015.

As of March 12, 2015, Camson Bio Technologies filed the application for Scheme of Arrangement (Demerger) of seeds business to Camson Seeds Limited with the Honourable High Court of Karnataka. As of April 23, 2015, the transaction is approved by the shareholders and creditors of Camson Bio and Camson Seeds.

Record date for distribution is September 22, 2015 and the transaction is expected to be effective On September 24, 2015.

Saffron Capital Advisors Private Limited acted as fairness opinion provider to Camson Bio Technologies Limited. M/S Bahubali Gouraj & Co. acted as accountant in the transaction.